Related Experiment Video
Updated: Aug 8, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Enfuvirtide (Fuzeon): the first fusion inhibitor
1Department of Sexually Transmitted Diseases, Royal Free & University College London Medical School, London, UK.
International Journal of Clinical Practice
|January 10, 2004
Summary
New HIV therapy enfuvirtide offers hope for patients with drug resistance or toxicity. This fusion inhibitor is suitable for those who have failed previous treatments, providing a vital new option in HIV management.
Area of Science:
- Infectious Diseases
- Pharmacology
- Virology
Background:
- Increasing HIV infection rates necessitate novel therapeutic strategies.
- Current antiretroviral therapies face challenges with drug resistance and long-term toxicity.
- A need exists for new treatment options for human immunodeficiency virus (HIV) infection.
Purpose of the Study:
- To review current practices in HIV infection management.
- To present clinical data on enfuvirtide, a novel fusion inhibitor.
- To discuss the integration of enfuvirtide into clinical practice.
Main Methods:
- Multidisciplinary discussion meeting.
- Review of existing clinical data on enfuvirtide.
- Analysis of enfuvirtide's role in HIV treatment regimens.
Main Results:
- Enfuvirtide is the first licensed fusion inhibitor for HIV treatment.
- Clinical data suggest enfuvirtide is effective in patients with prior treatment failure or intolerance.
- Optimal use involves combining enfuvirtide with other active antiretroviral agents.
Conclusions:
- Enfuvirtide represents a significant advancement in HIV therapy.
- It is indicated for patients with virological failure or intolerance to standard regimens.
- Strategic combination therapy is crucial for maximizing enfuvirtide's efficacy.
Related Concept Videos
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...